GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SOPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

SOPHiA GENETICS SA stock price ended at $4.80 on Thursday, after losing 1.03%.
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Loss -1.03% PDF

The SOPHiA GENETICS SA stock price fell by -1.03% on the last day (Thursday, 18th Apr 2024) from $4.85 to $4.80. During the last trading day the stock fluctuated 4.26% from a day low at $4.70 to a day high of $4.90. The price has fallen in 5 of the last 10 days and is down by -2.04% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -84 thousand shares and in total, 66 thousand shares were bought and sold for approximately $316.75 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.59% during the next 3 months and, with a 90% probability hold a price between $4.57 and $6.10 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SOPH Signals & Forecast

There are few to no technical positive signals at the moment. The SOPHiA GENETICS SA stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.94 and $4.89. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -8.75%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for SOPHiA GENETICS SA stock

SOPHiA GENETICS SA finds support from accumulated volume at $4.79 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.200 between high and low, or 4.26%. For the last week the stock has had daily average volatility of 5.60%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SOPH) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect SOPHiA GENETICS SA to open at $4.80, and during the day (based on 14 day Average True Range), to move between $4.45 and $5.15, which gives a possible trading interval of +/-$0.346 (+/-7.22%) up or down from last closing price. If SOPHiA GENETICS SA takes out the full calculated possible swing range there will be an estimated 14.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.79 (0.21%) than the resistance at $4.90 (2.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is SOPHiA GENETICS SA stock A Buy?

The SOPHiA GENETICS SA stock holds several negative signals and despite the positive trend, we believe SOPHiA GENETICS SA will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.007 Sell Candidate Unchanged

Predicted Opening Price for SOPHiA GENETICS SA of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$4.80 ( 0.00000000%) $4.80

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SOPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.00 4.17 %
R2 4.92 2.58 %
R1 4.88 1.59 %
Current price: 4.80
Support S1 4.72 -1.59 %
S2 4.68 -2.57 %
S3 4.60 -4.17 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.60 16.67 %
R2 5.08 5.83 %
R1 4.90 2.08 %
Current price 4.80
Support S1 4.79 -0.208%
S2 4.77 -0.625%
S3 4.66 -2.92%

FAQ

What is the symbol for SOPHiA GENETICS SA Stock and on which exchange is it traded?
The symbol for SOPHiA GENETICS SA is SOPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell SOPHiA GENETICS SA Stock?
The SOPHiA GENETICS SA stock holds several negative signals and despite the positive trend, we believe SOPHiA GENETICS SA will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy SOPHiA GENETICS SA Stock?
SOPHiA GENETICS SA Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy SOPHiA GENETICS SA Stock.

What's the current price of SOPHiA GENETICS SA Stock?
As of the end of day on the 2024-04-18, the price of an SOPHiA GENETICS SA (SOPH) share was $4.80.

What is the 52-week high and low for SOPHiA GENETICS SA Stock?
The 52-week high for SOPHiA GENETICS SA Stock is $7.37 and the 52-week low is $2.13.

What is the market capitalization of SOPHiA GENETICS SA Stock?
As of the 2024-04-18, the market capitalization of SOPHiA GENETICS SA is 316.712M.

When is the next earnings date for SOPHiA GENETICS SA?
The upcoming earnings date for SOPHiA GENETICS SA is May 14, 2024.
Click to get the best stock tips daily for free!

About SOPHiA GENETICS SA

SOPHiA GENETICS SA SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Su... SOPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT